Abstract
A series of potential HIV-1 integrase inhibitors based on 5-chloro-2-hydroxy-3-triazolylbenzoic acid scaffold was designed and synthesized. Some of these compounds exhibit potent inhibitory activities at micromolar concentrations against HIV-1 integrase in the 3′-end processing and the strand transfer step.
Graphical Abstract
Similar content being viewed by others
References
Anthony NJ (2004) HIV-1 integrase: a target for new AIDS chemotherapeutics. Curr Top Med Chem 4:979–990
Bacchi A, Carcelli M, Compari C, Fisicaro E, Pala N, Rispoli G, Rogolino D, Sanchez TW, Sechi M, Neamati N (2011a) HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding. Mol Pharm 8:507–519
Bacchi A, Carcelli M, Compari C, Fisicaro E, Pala N, Rispoli G, Rogolino D, Sanchez TW, Sechi M, Sinisi V, Neamati N (2011b) Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors. J Med Chem 54:8407–8420
Barral K, Moorhouse AD, Moses JE (2007) Efficient conversion of aromatic amines into azides: a one-pot synthesis of triazole linkages. Org Lett 9:1809–1811
Bock VD, Hiemstra H, van Maarseveen JH (2005) Cu(I)-catalyzed alkyne-azide click cycloadditions from a mechanistic and synthetic perspective. Eur J Org Chem 2006:51–68
Brouillette WJ, Saeed A, Abuelyaman A, Hutchison TL, Wolkowicz PE, McMillin JB (1994) Synthesis and enzymic evaluation of conformationally defined carnitine analogs. J Org Chem 59:4297–4303
Chiu TK, Davies DR (2004) Structure and function of HIV-1 integrase. Curr Top Med Chem 4:965–977
Dinges J, Albert DH, Arnold LD, Ashworth KL, Akritopoulou-Zanze I, Bousquet PF, Bouska JJ, Cunha GA, Davidsen SK, Diaz GJ, Djuric SW, Gasiecki AF, Gintant GA, Gracias VJ, Harris CM, Houseman KA, Hutchins CW, Johnson EF, Li H, Marcotte PA, Martin RL, Michaelides MR, Nyein M, Sowin TJ, Su Z, Tapang PH, Xia Z, Zhang HQ (2007) 1,4-Dihydroindeno[1,2-c]pyrazoles with acetylenic side chains as novel and potent multitargeted receptor tyrosine kinase inhibitors with low affinity for the hERG ion channel. J Med Chem 50:2011–2029
Drake R, Neamati N, Hong H (1998) Identification of a nucleotide binding site in HIV-1 integrase. Proc Natl Acad Sci USA 95:4170–4175
Esposito D, Craigie R (1999) HIV integrase structure and function. Adv Virus Res 52:319–333
Evering TH, Markowitz M (2008) Raltegravir: an integrase inhibitor for HIV-1. Expert Opin Invest Drug 17:413–422
Gupta SP, Nagappa AN (2003) Design and development of integrase inhibitors as anti-HIV agents. Curr Med Chem 10:1779–1794
Hazuda DJ, Yong SD, Guare JP, Anthony NJ, Gomez RP, Wai JS, Vacca JP, Handt L, Motzel SL, Klein HJ, Tussey L, Schleif WA, Gabryelski LS, Jin L, Miller MD, Casimiro DR, Emini EA, Shiver JW (2004) Integrase inhibitors and cellular immunity suppress retroviral replication in Rhesus Macaques. Science 305:528–532
Hou JL, Liu XF, Shen J, Zhao GL, Wang PG (2012) The impact of click chemistry in medicinal chemistry. Expert Opin Drug Discov 7:489–501
Inamoto K, Yamamoto A, Ohsawa K, Hiroya K, Sakamoto T (2005) Highly regioselective palladium-catalyzed annulation reactions of heteroatom-substituted allenes for synthesis of condensed heterocycles. Chem Pharm Bull 53:1502–1507
Jiao ZG, He HQ, Zeng CC, Tan JJ, Hu LM, Wang CX (2010) Design, synthesis and anti-HIV integrase evaluation of N-(5-chloro-8-hydroxy-2-styrylquinoline-7-yl)benzenesulfonamide derivatives. Molecules 15:1903–1917
Jing N, Marchad C, Liu J (2000) Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in vitro. J Biol Chem 275:21460–21467
Kawasuji T, Fuji M, Yoshinaga T, Sato A, Fujiwara T, Kiyama R (2006a) A platform for designing HIV integrase inhibitors. a two-metal binding model as a potential mechanism of HIV integrase inhibitors. Bioorganic Med Chem 14:8420–8429
Kawasuji T, Yoshinaga T, Sato A, Yodo M, Fujiwara T, Kiyama R (2006b) A platform for designing HIV integrase inhibitors. 2-Hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores. Bioorganic Med Chem 14:8430–8445
LaFemina RL, Schneider CL, Robbins HL, Callahan PL, LeGrow K, Roth E, Schleif WA, Emini EA (1992) Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells. J Virol 66:7414–7419
Ma SM, Wu B, Jiang XF (2005) PdCl2-catalyzed efficient transformation of propargylic amines to (E)-α-chloroalkylidene-β-lactams. J Org Chem 70:2588–2593
Marchand C, Christophe AA, Karki RG, Pais GC, Zhang XC, Cowansage K, Patel TA, Nicklaus MC, Burke TR, Pommier Y (2003) Metal-dependent inhibition of HIV-1 integrase by β-diketo acids and resistance of the soluble double-mutant (F185K/C280S). Mol Pharm 64:600–609
Mouscadet JF, Desmaele D (2010) Chemistry and structure-activity relationship of the styrylquinoline-type HIV integrase inhibitors. Molecules 15:3048–3078
Musser JH, Jones H, Sciortino S, Bailey K, Coutts SM, Khandwala A, Sonnino-Goldman P, Leibowitz M, Wolf P, Neiss ES (1985) Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines. J Med Chem 28:1255–1259
Reddy MV, Rao MR, Rhodes D, Hansen MS, Rubins K, Bushman FD, Venkateswarlu Y, Faulkner DJ (1999) Lamellarin α 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture. J Med Chem 42:1901–1907
Temesgen Z, Siraj DS (2008) Raltegravir: first in class HIV integrase inhibitor. Ther Clin Risk Manag 4:493–500
Trost BM, Xie J (2006) Palladium-catalyzed asymmetric ring expansion of allenylcyclobutanols: an asymmetric Wagner-Meerwein shift. J Am Chem Soc 128:6044–6045
Von Plessing B, Carlos (1963) Derivatives of 5-chlorosalicylic acid. Farm Nueva (Madrid) 28:439–446
Wang P, Liu C, Sanches T, Zhong Y, Liu B, Xiong J, Neamato N, Zhao GS (2009) Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester. Bioorganic Med Chem Lett 19:4574–4578
Xu YS, Zeng CC, Jiao ZG, Hu LM, Zhong RG (2009) Design, synthesis and anti-HIV integrase evaluation of 4-Oxo-4H-quinolizine-3-carboxylic acid derivatives. Molecules 14:868–883
Yang LF, Xu XM, Huang YL, Zhang B, Zeng CC, He HQ, Wang CX, Hu LM (2010) Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor. Bioorganic Med Chem Lett 20:5469–5471
Zeng J, Lu XH, Zeng CC, Hu LM, Zhong RG (2009) Design, synthesis and anti-HIV integrase evaluation of 1,2,3-triazol-4-yl-substituted 1,4-dihydro-4-oxo-1,5-naphthyridine-3-carboxylic acids. Chin J Chem 27:953–962
Zeng CC, Yang CW, Liu CF, Hu LM, Sheng W (2010) Preparation of 5-chloro-2-hydroxy-3-(4-substituted-1H-1,2,3-triazolyl)benzoic acid derivatives as HIV-1 integrase inhibitors Faming Zhuanli Shenqing, CN 101812028 A 20100825
Acknowledgments
This work was supported by Grants from the Beijing Natural Science Foundation (No. 7112008), and Fund to Zeng, C. C. from Beijing City Education Committee (KM201010005009). Zeng, C. C. thanks Ms. Chiu Marco Lam at UCSB for the languish polishing.
Conflict of interest
The authors confirm that this article content has no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, J., Liu, CF., Yang, CW. et al. Design and synthesis of 5-chloro-2-hydroxy-3-triazolylbenzoic acids as HIV integrase inhibitors. Med Chem Res 24, 2950–2959 (2015). https://doi.org/10.1007/s00044-015-1325-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-015-1325-9